Hyderabad: Champapet BJP corporator Vanga Madhusudan Reddy died on Saturday, according to his family members and political associates. Union minister Bandi Sanjay Kumar mourned his death, and ...

Dr. Reddy's Laboratories (RDY) on Wednesday announced that India’s drug regulator, the Drugs Controller General of India, has issued marketing and manufacturing authorization for a generic version of ...

Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Ozempic in March after Novo Nordisk AS's patent for the drug expires. That would make the Indian drugmaker one of the first ...

Hyderabad: Chief Minister A. Revanth Reddy commenced his executive education programme at the Kennedy School of Government at Harvard University in Cambridge, Massachusetts, US. The inaugural academic ...

Indian drugmaker Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March after the drug’s patent expiry, becoming one of the first firms to capture ...

Hyderabad: Chief minister A Revanth Reddy on Sunday began an executive education programme at Harvard University's Kennedy School in Cambridge, Massachusetts, marking a rare academic engagement by a ...

Good day, everyone, and welcome to the Quarter 3 FY '26 Earnings Call of Dr. Reddy's Laboratories Limited. We appreciate your continued interest in our company. I'm Aishwarya Sitharam, Head of ...

FREMONT, CA — From experiencing the driverless Waymo car in San Francisco, CA, to creating a new motto for Telangana to securing a series of investment deals and partnerships aimed at propelling ...

Dr Reddy’s share price: At around 10:55 AM, the stock was trading at Rs 1,217.20, up Rs 60.00 or 5.18 per cent. The share opened at Rs 1,195, touched a high of Rs 1,224.50 and a low of Rs 1,187.70.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active ...

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active ...